SYNTHESIS, CHARACTERISATION AND INVESTIGATION OF THE ANTICANCER POTENTIAL OF CARMOFUR-LOADED SILVER NANOPARTICLES; [KARMOFUR YÜKLÜ GÜMÜŞ NANOPARTİKÜLLERİNİN SENTEZİ, KARAKTERİZASYONU VE ANTİKANSER POTANSİYELİNİN ARAŞTIRILMASI]

ArticleAçık Erişim

Özet

Objective: The term "triple-negative breast cancer" (TNBC) is used to describe tumours that do not express oestrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2). TNBC tends to be more aggressive than other types of breast cancer. Current antineoplastic drugs have limited treatment options for malignant breast cancer owing to their narrow therapeutic index, toxicity, resistance, and nonselectivity. Therefore, there is a need for the prompt development of new medicinal drugs for TNBC. Here, we investigated the growth inhibition potential of carmofur-bonded silver nanoparticles (AgNPs-Car) on two TNBC cell lines, MDA-MB-231 and 4T1, and compared the effects with non-cancerous Human umbilical vein endothelial cells (HUVECs). Material and Methods: AgNPs-Car were synthesised and characterised by FTIR, DLS, SEM, and EDX. The anticancer effect was evaluated using a 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Results: AgNPs-Car was determined to be predominantly more effective than Car alone. Mainly, 4T1 cells were 5.7-fold more sensitive to AgNPs-Car than Car alone. While AgNPs showed no considerable toxicity on HUVECs, they significantly induced the cytotoxicity of MDA-MB-231 and 4T1 cells. Conclusion: Our results showed that AgNPs-Car is a promising anticancer agent due to its highly potent and selective growth inhibitory effect on TNBC cells. © 2025 Istanbul University Press. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11027Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.26650/iuitfd.1567946Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDanışmanKalindemi̇rtaş, Ferdane
dc.contributor.authorKari̇per, İshak Afşin
dc.contributor.authorÖzerkan, Dilşad
dc.contributor.authorKuruca, Dürdane Serap
dc.date.accessioned2026-10-18T20:26:08.018467593Z
dc.date.available2026-10-18T20:26:08.018467593Z
dc.date.issued2025
dc.description.abstractObjective: The term "triple-negative breast cancer" (TNBC) is used to describe tumours that do not express oestrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER2). TNBC tends to be more aggressive than other types of breast cancer. Current antineoplastic drugs have limited treatment options for malignant breast cancer owing to their narrow therapeutic index, toxicity, resistance, and nonselectivity. Therefore, there is a need for the prompt development of new medicinal drugs for TNBC. Here, we investigated the growth inhibition potential of carmofur-bonded silver nanoparticles (AgNPs-Car) on two TNBC cell lines, MDA-MB-231 and 4T1, and compared the effects with non-cancerous Human umbilical vein endothelial cells (HUVECs). Material and Methods: AgNPs-Car were synthesised and characterised by FTIR, DLS, SEM, and EDX. The anticancer effect was evaluated using a 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Results: AgNPs-Car was determined to be predominantly more effective than Car alone. Mainly, 4T1 cells were 5.7-fold more sensitive to AgNPs-Car than Car alone. While AgNPs showed no considerable toxicity on HUVECs, they significantly induced the cytotoxicity of MDA-MB-231 and 4T1 cells. Conclusion: Our results showed that AgNPs-Car is a promising anticancer agent due to its highly potent and selective growth inhibitory effect on TNBC cells. © 2025 Istanbul University Press. All rights reserved.
dc.description.sponsorshipWe thank Kadriye G\u00FCm\u00FC\u015F for her contribution to the English editing of the article at the Istanbul Faculty of Medicine.
dc.identifier.doi10.26650/iuitfd.1567946
dc.identifier.eissn1305-6441
dc.identifier.endpage127
dc.identifier.issn1305-6433
dc.identifier.issue2
dc.identifier.scopus2-s2.0-105003688949
dc.identifier.startpage118
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11027
dc.identifier.volume88
dc.identifier.wosWOS:001472955800001
dc.language.isoen
dc.publisherIstanbul University Press
dc.relation.ispartofIstanbul Tip Fakultesi Dergisi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectanticancer
dc.subjectantiproliferative
dc.subjectCarmofur
dc.subjectSilver nanoparticles
dc.subjecttriple-negative breast cancer cells
dc.titleSYNTHESIS, CHARACTERISATION AND INVESTIGATION OF THE ANTICANCER POTENTIAL OF CARMOFUR-LOADED SILVER NANOPARTICLES; [KARMOFUR YÜKLÜ GÜMÜŞ NANOPARTİKÜLLERİNİN SENTEZİ, KARAKTERİZASYONU VE ANTİKANSER POTANSİYELİNİN ARAŞTIRILMASI]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.trdizin0
rdl.citation.wos0
rdl.departmentKASTAMONU ÜNİVERSİTESİ
rdl.departmentİSTANBUL ATLAS ÜNİVERSİTESİ
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentERCİYES ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)